OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
|Articles|October 1, 2005
- Volume 0 0
Drug Chains Urge National OTC Drug Rules
Author(s)Ken Rankin
Advertisement
A flurry of new and conflicting stateand local laws regulating the sale ofOTC cold products containing pseudoephedrineis creating complianceproblems for drug chains operating inmultiple jurisdictions.
Chain drugstore leaders urged Congressto adopt a national standard forthe sale of OTC cold drugs. They warnedthat a "patchwork" system of differingstate and local restrictions on the sale ofthese drugs will actually play into thehands of criminals seeking source materialfor illegal methamphetamine.
Mr. Rankin is a freelance medical writer.
Articles in this issue
about 21 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsabout 21 years ago
Dangerous Liaisons: Schizophrenia and Diabetesabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplementsabout 21 years ago
Tarceva Extends Lung Cancer Survivalabout 21 years ago
Inhaled Morphine Aids Cancer-related Dyspneaabout 21 years ago
Diuretic Best BP Therapy for African Americansabout 21 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsabout 21 years ago
New Drug Blocks Out AIDS Virusabout 21 years ago
Viagra Ingredient Has Another Useabout 21 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIAAdvertisement
Related to this article
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
3
The Most Accessible Healthcare Professional—But Accessible to Whom?
4
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
5